Total Payments
$7,382
2024 Payments
$265.59
Companies
33
Transactions
284
Medicare Patients
881
Medicare Billing
$169,979
Payment Breakdown by Category
Food & Beverage$5,205 (70.5%)
Consulting$1,890 (25.6%)
Education$287.02 (3.9%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,205 | 276 | 70.5% |
| Consulting Fee | $1,890 | 3 | 25.6% |
| Education | $287.02 | 5 | 3.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,581 | 46 | $0 (2021) |
| Abbott Laboratories | $813.48 | 27 | $0 (2021) |
| Lilly USA, LLC | $735.87 | 56 | $0 (2022) |
| AstraZeneca Pharmaceuticals LP | $569.75 | 27 | $0 (2022) |
| Dexcom, Inc. | $341.41 | 20 | $0 (2023) |
| Corcept Therapeutics | $332.16 | 5 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $291.24 | 17 | $0 (2021) |
| Amgen Inc. | $274.28 | 16 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $190.82 | 6 | $0 (2018) |
| Medtronic MiniMed, Inc. | $161.04 | 8 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $265.59 | 2 | Corcept Therapeutics ($135.81) |
| 2023 | $60.01 | 1 | Dexcom, Inc. ($60.01) |
| 2022 | $189.81 | 10 | Lilly USA, LLC ($51.84) |
| 2021 | $1,085 | 59 | Lilly USA, LLC ($227.70) |
| 2020 | $2,130 | 14 | Novo Nordisk Inc ($1,890) |
| 2019 | $1,234 | 67 | Abbott Laboratories ($271.93) |
| 2018 | $1,879 | 108 | Abbott Laboratories ($417.79) |
| 2017 | $537.23 | 23 | Janssen Pharmaceuticals, Inc ($146.10) |
All Payment Transactions
284 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/08/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $129.78 | General |
| Category: Automated insulin delivery system | ||||||
| 03/20/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $135.81 | General |
| Category: Endocrinology | ||||||
| 03/20/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $60.01 | General |
| Category: Endocrinology | ||||||
| 02/18/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: Diabetes | ||||||
| 02/07/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Endocrinology | ||||||
| 02/02/2022 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Endocrinology | ||||||
| 02/01/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/25/2022 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Diabetes | ||||||
| 01/24/2022 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Endocrinology | ||||||
| 01/19/2022 | Mannkind Corporation | AFREZZA (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: DIABETES MEDICINE | ||||||
| 01/13/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: TEPEZZA | ||||||
| 01/11/2022 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Endocrinology | ||||||
| 01/05/2022 | Lilly USA, LLC | BAQSIMI (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: Diabetes | ||||||
| 12/16/2021 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: Cardiology | ||||||
| 12/13/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Diabetes | ||||||
| 12/06/2021 | PFIZER INC. | SOMAVERT (Drug), GENOTROPIN | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: ENDOCRINE DISEASE;METABOLIC DISEASE | ||||||
| 12/02/2021 | Lilly USA, LLC | TRULICITY (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: Diabetes | ||||||
| 12/01/2021 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: TEPEZZA | ||||||
| 11/29/2021 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: Cardio-renal | ||||||
| 11/23/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $17.38 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/05/2021 | Abbott Laboratories | FreeStyle Libre (Device) | Food and Beverage | In-kind items and services | $25.92 | General |
| Category: Diabetes Care | ||||||
| 10/28/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $12.45 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/27/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/21/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $7.33 | General |
| Category: Diabetes | ||||||
| 10/13/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 405 | 2,031 | $478,953 | $112,538 |
| 2022 | 5 | 189 | 283 | $99,092 | $21,728 |
| 2021 | 4 | 143 | 236 | $53,707 | $21,028 |
| 2020 | 3 | 144 | 197 | $42,317 | $14,684 |
Total Patients
881
Total Services
2,747
Medicare Billing
$169,979
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 171 | 1,498 | $299,300 | $75,865 | 25.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 136 | 416 | $140,260 | $29,241 | 20.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 61 | 61 | $31,063 | $5,838 | 18.8% |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 2023 | 15 | 20 | $3,500 | $857.41 | 24.5% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 11 | 19 | $2,280 | $392.64 | 17.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 11 | 17 | $2,550 | $343.91 | 13.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 97 | 186 | $60,152 | $13,621 | 22.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 53 | 53 | $26,854 | $5,281 | 19.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 16 | $7,134 | $1,809 | 25.4% |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | Office | 2022 | 13 | 15 | $2,625 | $687.15 | 26.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 13 | $2,327 | $329.81 | 14.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 79 | 165 | $39,765 | $15,913 | 40.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 37 | 41 | $6,724 | $2,465 | 36.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 16 | 16 | $5,888 | $2,284 | 38.8% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 11 | 14 | $1,330 | $366.00 | 27.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 70 | 100 | $16,400 | $6,421 | 39.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 54 | 77 | $18,557 | $5,903 | 31.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 20 | 20 | $7,360 | $2,360 | 32.1% |
About Dr. Stuart Seigel, MD
Dr. Stuart Seigel, MD is a Internal Medicine healthcare provider based in Laguna Niguel, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2008. The National Provider Identifier (NPI) number assigned to this provider is 1073763983.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stuart Seigel, MD has received a total of $7,382 in payments from pharmaceutical and medical device companies, with $265.59 received in 2024. These payments were reported across 284 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($5,205).
As a Medicare-enrolled provider, Seigel has provided services to 881 Medicare beneficiaries, totaling 2,747 services with total Medicare billing of $169,979. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Diabetes & Metabolism|Endocrinology, Diabetes & Metabolism
- Location Laguna Niguel, CA
- Active Since 09/27/2008
- Last Updated 03/17/2018
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1073763983
Products in Payments
- RYBELSUS (Drug) $1,943
- FARXIGA (Drug) $569.75
- Korlym (Drug) $332.16
- FreeStyle Libre blood glucose Flash Monitoring System (Device) $324.59
- Ozempic (Drug) $277.58
- FreeStyle Libre (Device) $242.49
- HUMULIN (Drug) $214.85
- INVOKANA (Drug) $190.82
- FreeStyle Lite system (Device) $153.20
- TRULICITY (Drug) $152.40
- Prolia (Biological) $130.90
- iLet Bionic Pancreas (Device) $129.78
- AFREZZA (Drug) $129.33
- Saxenda (Drug) $121.08
- Minimed 630G (Device) $114.93
- Synthroid (Drug) $103.82
- Dexcom G6 Transmitter (Medical Supply) $100.07
- BAQSIMI (Drug) $96.61
- TOUJEO (Drug) $95.63
- FreeStyle Freedom Lite system (Device) $93.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Laguna Niguel
Warner Carr, Md, MD
Internal Medicine — Payments: $633,974
Internal Medicine $633,974
Dr. Amitpal Kohli, M.d, M.D
Internal Medicine — Payments: $9,181
Internal Medicine $9,181
Dr. Christine Lee-Kim, D.o, D.O
Internal Medicine — Payments: $6,487
Internal Medicine $6,487
Bassam Bilal, M.d, M.D
Internal Medicine — Payments: $4,209
Internal Medicine $4,209
Dr. Zahra Shahim, Md, MD
Internal Medicine — Payments: $3,656
Internal Medicine $3,656
Dr. Susan Dindot, Md, MD
Internal Medicine — Payments: $2,425
Internal Medicine $2,425